Coronavirus

Coronavirus

Biodefense Headlines – April 30, 2026

News Scan April 30, 2026

This week’s selections include cascading institutional disruptions reshaping U.S. public health and science governance — including the Trump administration’s mass firing of the National Science Board and restrictions on graduate…

Inovio’s Positive First-in-Human MERS Vaccine Results Published in The Lancet Infectious Diseases

Complete Genome Sequence of a SARS-Related Coronavirus from Kenyan Bats

Should We Be Worried About the New Coronavirus?

Adaptive Evolution of MERS-CoV to Infect Different Species

MERS-CoV: Clinical Trial Starts for Regeneron’s Monoclonal Antibody Treatments

Experimental MERS Antibody Therapeutics Enter Clinical Trial

Turnkey Detection: Rapid Diagnostics in the Field

BARDA Backs Antibody Therapy Against MERS Virus

First-In-Human Study of MERS Vaccine Completes Enrollment

NIH Evaluating New Antibody Treatment for MERS-CoV

MERS-CoV Less Virulent During Outbreak?

MERS-CoV Likely Began in Bats, Moved to Camels, Then People

Walter Reed Kicks Off Phase 1 MERS Vaccine Trial

Inovio and GeneOne Kick Off MERS Vaccine Trial

Report Outlines Framework for Global Pandemic Preparedness

New Vaccine Against MERS Tested on Dromedary Camels

Rapid Medical Countermeasure Response to Infectious Diseases

Kenya: MERS Virus Widespread in Camels

Notable Contracts: BioFire Respiratory Panels for NAMRU-6

IVI Initiates MERS Vaccine Research and Development

Biodefense Headlines – April 30, 2026